Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: May 5, 2025
Medite Cancer Diagnostics Market Cap
Medite Cancer Diagnostics has a market cap or net worth of $8.58 thousand as of July 22, 2025. Its market cap has decreased by -99.80% in one year.
Market Cap
8.58K
Enterprise Value
n/a
Revenue
8.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 7, 1998, Medite Cancer Diagnostics's market cap has decreased from 591.70K to 8.58K, a decrease of -98.55%. That is a compound annual growth rate of -14.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.66B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 568.58M |
| Glass House Brands | 434.98M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 364.65M |